Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor And PrEconditioning in patients with stable coronary artery disease
2016-004746-28Phase 4Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor in coronary arteriosclerosis (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Delta ST-segment elevation during intracoronary ECG with sequential balloon inflations. Started Mar 2019; status: terminated.
02
Drugs
ticagrelor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2016-004746-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004746-28.